These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

97 related items for PubMed ID: 14737946

  • 1. Impact of interferon-alpha therapy on the serum level of alpha-fetoprotein in patients with chronic viral hepatitis.
    Kasztelan-Szczerbińska B, Słomka M, Celiński K, Szczerbiński M.
    Rocz Akad Med Bialymst; 2003; 48():74-7. PubMed ID: 14737946
    [Abstract] [Full Text] [Related]

  • 2. Interferon-alfa treatment may reduce the occurrence of liver carcinogenesis in patients with chronic viral hepatitis.
    Kasztelan-Szczerbińska B, Słomka M, Celiński K, Lozowski CT, Daniluk J, Szczerbiński M.
    Ann Univ Mariae Curie Sklodowska Med; 2003; 58(1):280-5. PubMed ID: 15314999
    [Abstract] [Full Text] [Related]

  • 3. Viral interaction and responses in chronic hepatitis C and B coinfected patients with interferon-alpha plus ribavirin combination therapy.
    Chuang WL, Dai CY, Chang WY, Lee LP, Lin ZY, Chen SC, Hsieh MY, Wang LY, Yu ML.
    Antivir Ther; 2005; 10(1):125-33. PubMed ID: 15751770
    [Abstract] [Full Text] [Related]

  • 4. Evolution of hepatitis C virus-specific T cell responses and cytokine production in chronic hepatitis C patients treated with high doses of interferon-alpha.
    Alvarado Esquivel C, Elewaut A, Philippé J, Elewaut AE, Desombere I, Maertens G, Leroux-Roels G.
    Rev Invest Clin; 2002; 54(1):41-50. PubMed ID: 11995406
    [Abstract] [Full Text] [Related]

  • 5. Early response to interferon alpha treatment and long-term clinical outcome in Japanese patients with chronic HBV genotype C infection.
    Seo Y, Yoon S, Hamano K, Nakaji M, Yano Y, Katayama M, Ninomiya T, Hayashi Y, Kasuga M.
    Int J Mol Med; 2004 Jan; 13(1):75-9. PubMed ID: 14654974
    [Abstract] [Full Text] [Related]

  • 6. Effectiveness of lamivudine and interferon-alpha combination therapy versus interferon-alpha monotherapy for the treatment of HBeAg-negative chronic hepatitis B patients: a randomized clinical trial.
    Karabay O, Tamer A, Tahtaci M, Vardi S, Celebi H.
    J Microbiol Immunol Infect; 2005 Aug; 38(4):262-6. PubMed ID: 16118673
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Efficacy of interferon retreatment after relapse for chronic hepatitis C patients with biochemical response after first interferon therapy.
    Arase Y, Ikeda K, Tsubota A, Suzuki Y, Saitoh S, Kobayashi M, Suzuki F, Akuta N, Someya T, Hosaka T, Kobayashi M, Kumada H.
    J Gastroenterol; 2004 Aug; 39(5):455-60. PubMed ID: 15175944
    [Abstract] [Full Text] [Related]

  • 10. Long-term follow-up after successful interferon therapy of acute hepatitis C.
    Wiegand J, Jäckel E, Cornberg M, Hinrichsen H, Dietrich M, Kroeger J, Fritsch WP, Kubitschke A, Aslan N, Tillmann HL, Manns MP, Wedemeyer H.
    Hepatology; 2004 Jul; 40(1):98-107. PubMed ID: 15239091
    [Abstract] [Full Text] [Related]

  • 11. Long-term follow-up of alpha-interferon treatment of patients with chronic hepatitis B.
    van Zonneveld M, Honkoop P, Hansen BE, Niesters HG, Darwish Murad S, de Man RA, Schalm SW, Janssen HL.
    Hepatology; 2004 Mar; 39(3):804-10. PubMed ID: 14999700
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Comparison of interferon and lamivudine treatment in Japanese patients with HBeAg positive chronic hepatitis B.
    Arase Y, Ikeda K, Suzuki F, Suzuki Y, Kobayashi M, Akuta N, Hosaka T, Sezaki H, Yatsuji H, Kawamura Y, Kobayashi M, Kumada H.
    J Med Virol; 2007 Sep; 79(9):1286-92. PubMed ID: 17607775
    [Abstract] [Full Text] [Related]

  • 16. Twenty-four hour kinetics of hepatitis C virus and antiviral effect of alpha-interferon.
    Boulestin A, Kamar N, Sandres-Sauné K, Legrand-Abravanel F, Alric L, Vinel JP, Rostaing L, Izopet J.
    J Med Virol; 2006 Mar; 78(3):365-71. PubMed ID: 16419107
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.